Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology
Scientific Editors:George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago
Michael Gnant
In this edition:
1. Zoledronic Acid Reduces Recurrence In Early-Stage Breast Cancer
Michael Gnant, Medical University of Vienna, AustriaABSTRACT: LBA4
2. Bevacizumab Slows Progression In Advanced Breast Cancer
David Miles, Mount Vernon Cancer Centre, LondonABSTRACT: LBA 1011
3. Discussion: Zoledronic Acid; Bevacizumab in Breast Cancer
Eric Winer, Dana-Farber Cancer Institute, BostonABSTRACT: LBA 4 & LBA 1011
4. Oral Capecitabine: Not For Older Patients with Early Breast Cancer
Hyman Muss, University of Vermont, BurlingtonABSTRACT: 507
5. Endometrial Cancer: Brachytherapy Is Better
Remi Nout, Leiden University Medical CenterABSTRACT: LBA 5503
6. Adjuvant Gemcitabine Doubles Survival In Resected Pancreas Cancer
Helmut Oettle, Charité University, BerlinABSTRACT: LBA 4504
7. Everolimus Delays Metastatic Kidney Cancer Progression
Robert Motzer, Memorial Sloan-Kettering Cancer Center, New YorkABSTRACT: LBA 5026
8. Discussion: Gemcitabine For Pancreas Cancer; Brachytherapy for Endometrial Cancer
Nicholas Petrelli, Helen F Graham Cancer Center, WilmingtonABSTRACTS: LBA 5503; LBA 4504; LBA5026
Buy Audio Journal of Oncology Digital CopyOrder Audio Journal of Oncology CDLISTEN
Related Episodes
Jefferson DeKloe BSc: Big US Study Confirms Benefit of HPV Vaccination for Boys as Well as Girls
The cancer prevention benefit of vaccination against the human papilloma virus cancer prevent are slowly accruing thanks to European, American and other population-based studies. I’m Peter Goodwin wi
Luis Paz-Ares MD PhD: Longer Survival Among Patients with Extensive Stage Small Cell Lung Cancer Treated with Lurbinectedin Maintenance —ASCO 2025
Luis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)
Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab Added to Standard Chemotherapy
An interview with: Frank A Sinicrope, MD, Medical Oncologist, Mayo Clinic, Rochester, Minnesota. CHICAGO —Big gains in survival have been reported among patients with stage three, node-positive colon